Ru-106 Eye Applicators
AwardHighlights
- Award value
- —
- Winning supplier
- Eckert & Ziegler BEBIG GmbH
- Award date
- —
Details
- Published
- 10 Sept 2026
- Deadline
- —
- Value
- —
- Location
- UKM82
- Source
- Find a Tender
- Source notice ID
- 085901-2026
- OCID
- ocds-h6vhtk-06e1b8
- CPV codes
- 33151000
Description
NHS Greater Glasgow and Clyde intends to purchase Ru-106 Eye Applicators from Eckert & Ziegler for specialist ocular brachytherapy treatments delivered within NHS Scotland.
The purchase includes the supply of radioactive Ru-106 ophthalmic applicators and associated technical support services as required by the clinical service.
Similar opportunities
- Dental Equipment, Consumables & SolutionsTenderSupply Chain Coordination LimitedCloses 11 Nov 2026
- NHS National Framework for Generics Orals, Non-Parenteral & HousekeepingTenderNHS EnglandCloses 19 Oct 2026
- ShopmobilityTenderSandwell Metropolitan Borough CouncilCloses 22 Sept 2026
- PURCH3013 Provision of Contract Agreement for Manufacture of Investigational Medicinal Products for a Clinical TrialTenderUniversity of GlasgowCloses 19 Oct 2026
- PURCH3013 Provision of Contract Agreement for Manufacture of Investigational Medicinal Products for a Clinical TrialTenderUniversity of GlasgowCloses 19 Oct 2026
More from NHS Greater Glasgow and Clyde
View all- 2627 DS106 Multitone PagingAwardNHS Greater Glasgow and ClydeAwarded
- 2627 DS106 Multitone PagingAwardNHS Greater Glasgow and ClydeAwarded £236,689
- Award of GGC1123 Mini Competition for Outsourcing Support - Medical Procedures, from DPS NP648.22AwardNHS Greater Glasgow and ClydeAwarded £2,630,991
- Award of GGC1123 Mini Competition for Outsourcing Support - Medical Procedures, from DPS NP648.22AwardNHS Greater Glasgow and ClydeAwarded £2,630,991
- CivTech 12 - Challenge 12.4 - How can technology improve both the efficiency and the patient experience in NHS transport, starting with renal services?TenderNHS Greater Glasgow and ClydeCloses 20 Oct 2026
Lots (1)
| Lot | Title | Value |
|---|---|---|
| 1 | Ru-106 eye applicators are ophthalmic brachytherapy plaques used primarily for treating uveal melanoma, retinoblastoma, and other ocular tumors. They consist of a thin film of Ru-106 beta-emitting isotope, encapsulated in pure silver sheets, with a total thickness of only 1 mm, making them easy to handle and position on the eye surface. The beta radiation has a limited range, allowing high doses to tumors up to 5 mm in thickness while sparing sensitive structures like the optic disc and fovea. ARu-106 eye applicators are ophthalmic brachytherapy plaques used primarily for treating uveal melanoma, retinoblastoma, and other ocular tumors. They consist of a thin film of Ru-106 beta-emitting isotope, encapsulated in pure silver sheets, with a total thickness of only 1 mm, making them easy to handle and position on the eye surface. The beta radiation has a limited range, allowing high doses to tumors up to 5 mm in thickness while sparing sensitive structures like the optic disc and fovea. Additional information: Approximately six (6) Ru-106 Eye Applicators required to be purchased and returned per year, this contract will cover a 36 month period | — |
Awarded contracts (1)
| Title | Supplier | Value | Awarded |
|---|---|---|---|
| Award 085901-2026-MM/EZ/2026-1 | Eckert & Ziegler BEBIG GmbH | — | — |